Analyze PCRX

ShareShare on WhatsApp Share on Facebook Share on X

Equity Research · Deep diveIT-2026-PCRX · 2026-07-30

Pacira BioSciences, Inc. (PCRX)

HealthcareDrug Manufacturers - Specialty & GenericNasdaqGSMarket cap $1.04B

$26.40

-1.53%

Analyst-style PDF, emailed within minutes

78/100

Strong positive signal

Automated weighted score · not a recommendation

Price source: Yahoo · live price · as of 23:00 · Data: Yahoo · SEC EDGAR · FINRA · Wikidata

About the company

Market cap

$1.04B

P/E

203.08

Beta

0.27

Employees

825

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: NasdaqGSCountry: United States Website

What the company does

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Day range

$26.13$27.01

52-week range

$18.80$27.64

Price alert on PCRX

Get an in-app and mobile alert every time PCRX crosses a price you set.

Loading short data…

PCRX · Chart

Loading chart…

SMA20 SMA50 SMA200

Charts by TradingView

Support & resistance

Key trading levels, by timeframe

Day

Swing

Computing levels…

The technical signal compass

Sign up free and build your own trading bot with full backtesting. Live bots, real-time alerts and the bot gallery — with a Pro subscription.

Free sign-up

Pacira BioSciences, Inc. (PCRX) is trading around $26.40 (-1.53% on the last session). Its 52-week range runs from $18.80 to $27.64. Technically: 9 buy signals, 0 sell and 3 neutral. It belongs to the Healthcare sector (Drug Manufacturers - Specialty & Generic), with a P/E of 203.1 and a 1B$ market cap. Data sourced from Yahoo · live price as of 23:00. This is data analysis only, not advice or a recommendation.

PCRX stock FAQ

What is PCRX's current price?

PCRX is trading around $26.40 (-1.53%), as of 23:00 per Yahoo · live price.

What is PCRX's 52-week price range?

Over the last 52 weeks PCRX ranged between a $18.80 low and a $27.64 high.

Which sector does PCRX belong to?

PCRX belongs to the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

Disclosure & disclaimer: All information, scores, signals and trade plans on this site are produced by an automated algorithmic system and are based on technical and quantitative data only. They do not constitute investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional that accounts for your needs and circumstances. We are not investment advisors. Trading securities involves substantial risk, up to the loss of your entire investment; every decision and action is your sole responsibility. i-trade and its operators bear no liability for any direct or indirect damage arising from reliance on this information.

0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼# € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1買 0 0 買 ↑ % 0 ▼ ₿ $ $ ₿ ▼ 0 % ↑ 買 0 0 買 ↑ %€ ↓ ↓ € ▲ 売 # 1 1 ◇ ◇ 1 1 # 売 ▲ € ↓ ↓ € ▲ 売0 ▼ ▼ 0 0 ₿ 買 % $ ↑ ↑ $ % 買 ₿ 0 0 ▼ ▼ 0 0 ₿↓ 1 1 ↓ # 1 € 売 ◇ ▲ ▲ ◇ 売 € 1 # ↓ 1 1 ↓ # 1▼ % % ▼ 買 $ 0 ₿ ↑ 0 0 ↑ ₿ 0 $ 買 ▼ % % ▼ 買 $1 売売 1 € ◇ ↓ 1 ▲ # # ▲ 1 ↓ ◇ € 1 売売 1 € ◇% ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲₿ $ $ ₿ ▼ 0 % ↑ 買 0 0 買 ↑ % 0 ▼ ₿ $ $ ₿ ▼ 01 ◇ ◇ 1 1 # 売 ▲ € ↓ ↓ € ▲ 売 # 1 1 ◇ ◇ 1 1 #$ ↑ ↑ $ % 買 ₿ 0 0 ▼ ▼ 0 0 ₿ 買 % $ ↑ ↑ $ % 買◇ ▲ ▲ ◇ 売 € 1 # ↓ 1 1 ↓ # 1 € 売 ◇ ▲ ▲ ◇ 売 €↑ 0 0 ↑ ₿ 0 $ 買 ▼ % % ▼ 買 $ 0 ₿ ↑ 0 0 ↑ ₿ 0▲ # # ▲ 1 ↓ ◇ € 1 売売 1 € ◇ ↓ 1 ▲ # # ▲ 1 ↓0 買買 0 $ ▼ ↑ 0 % ₿ ₿ % 0 ↑ ▼ $ 0 買買 0 $ ▼# € € # ◇ 1 ▲ ↓ 売 1 1 売 ↓ ▲ 1 ◇ # € € # ◇ 1

Building the strategy

PCRX stock FAQ

What is PCRX's current price?

PCRX is trading around $26.40 (-1.53%), as of 23:00 per Yahoo · live price.

What is PCRX's 52-week price range?

Over the last 52 weeks PCRX ranged between a $18.80 low and a $27.64 high.

Which sector does PCRX belong to?

PCRX belongs to the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

Analyze PCRX

Pacira BioSciences, Inc. (PCRX)

About the company

PCRX · Chart

Support & resistance

The technical signal compass

PCRX stock FAQ

Pacira BioSciences, Inc. (PCRX)

About the company

PCRX · Chart

Support & resistance

The technical signal compass

PCRX stock FAQ

Income statement analysis

Institutional & insider data

Full analyst coverage